DV
Dividend Vision

GRI — GRI Bio Inc.

GRI Bio Inc. (GRI)

Total return is -100.0% over the past 5.5 years, 214.3 points behind SPY at 114.3%. Its deepest 1-year drawdown was 97.8%.

GRI Bio Inc. is an equity fund that focuses on biotechnology and life sciences companies. With limited publicly available data on its distribution frequency, yield profile, and expense ratio, the fund appears designed for investors interested in exposure to the biotech sector, though specific income characteristics are not clearly defined in the available information.

GRI key facts

Asset type
Stock
Asset class
Equity
Inception date
02/10/2021
Last close
$1.67
Market cap
$2,656,257
Average volume
105200.0
Beta
-0.673
Payout ratio
0.0
P/E ratio
0.0386
Forward P/E
0.0
EPS
$38.89